These include a potential for myocarditis, and development of coronary artery abnormalities, ischemia and the risk of TB and cancer (mainly lymphomas in patients receiving etanercept) although the existence of a cause and effect relationship between anti-TNF use and lymphomas remains controversial [37]. The gene discussed is TNF; the disease is lymphoma.